Antisense modulation of RIP2 expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 30, 2002
Grant Date -
N/A
app pub date -
Aug 1, 2001
filing date -
Aug 1, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of RIP2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding RIP2. Methods of using these compounds for modulation of RIP2 expression and for treatment of diseases associated with expression of RIP2 are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully